TrialInvestigational new drugs2019

Safety, tolerability, and pharmacology of AB928, a novel dual adenosine receptor antagonist, in a randomized, phase 1 study in healthy volunteers.

Lisa Seitz et al.PubMed ↗Publisher ↗

No numbers read from the abstract.